Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Direxion S&P Biotech Bull 3X (NY: LABU)
87.38 USD  -1.64 (-1.84%)
Official Closing Price  /  Updated: 8:00 PM EDT, Aug 20, 2018  /  Add to My Watchlist      
View: Quote News
Fund Overview
Direxion S&P Biotech Bull 3X
Sector
Exchange Traded NY
Net Assets 376.75M
Inception Date
Related Funds
Quote
Price 87.38
Volume 735,600
Last Trade Aug 20, 8:00pm
Change (%)
-1.64 (-1.84%)
Prev. Close 89.02
YTD %
+3.91%
Dividend Yield 0.17%
Performance
YTD
+3.29 (3.91%)
1 Month
-21.13 (-19.47%)
3 Month
+0.59 (0.68%)
6 Month
-3.10 (-3.43%)
1 Year
+30.18 (52.76%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Best & Worst Weekly Performers: July 28 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Exploring The Leveraged ETF Trade Heading Into Earnings Season
The second quarter earnings season is upon us, meaning traders and investors are primed to take advantage of volatile moves in ... Read More
from Benzinga
Top News
More News
Best & Worst Weekly Performers: July 14 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Pharma, Biotech Bull ETFs Leading the Charge
The rising prices of drug treatments, more dependence on immuno-oncology and mergers focused on mid-sized biotech company acquisitions are just a few factors spurning the growth in the biotechnology... Read More
from ETF Trends
Best & Worst Weekly Performers: July 7 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Buy on the Dip Prospects: July 2 Edition
Below is a look at ETFs that currently offer attractive buying opportunities. The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be in... Read More
from ETFdb
Best & Worst Weekly Performers: June 30 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
5 Big Direxion ETFs Trending This Week
Since 1997, Direxion has been providing investment solutions with their innovative ETFs and 20 years later, they have $13.4 billion worth of assets under management. If you haven’t already, check out... Read More
from ETF Trends
Buy on the Dip Prospects: June 11 Edition
Below is a look at ETFs that currently offer attractive buying opportunities. The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be in... Read More
from ETFdb
7 Top Performing Leveraged ETFs of May
The frequent change in sentiments raised the appeal of leveraged ETFs as investors sought to register big gains in a short span. Read More
from Blogs - TalkMarkets
Best & Worst Weekly Performers: June 2 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Best & Worst Weekly Performers: May 19 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Best & Worst Weekly Performers: May 12 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Daily S&P Biotech Bull 3X Shares (LABU) Shares Cross Above 200 DMA
In trading on Wednesday, shares of the Daily S&P Biotech Bull 3X Shares ETF (LABU) crossed above their 200 day moving average of $80.10, changing hands as high as $83.08 per share. Daily S&P Biotech... Read More
from ETF Channel
The Week Ahead: Nvidia And Dropbox Earnings, April Retail Sales, Trump Drug Pricing Speech Expected
Below is a list of notable corporate events for the week beginning May 7. Note, this list is not comprehensive and all dates are subject ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.